Previous studies indicating that postabsorptive renal glucose production is negligible used the net balance technique, which cannot partition simultaneous renal glucose production and glucose uptake. 10 d after surgical placement of sampling catheters in the left renal vein and femoral artery and a nonobstructive infusion catheter in the left renal artery of dogs, systemic and renal glucose and glycerol kinetics were measured with peripheral infusions of 13-3Hjglucose and [2-14Cjglycerol.
Introduction
The role of the kidney in glucose metabolism is thought to be minor under most circumstances. Cahill et al. (1) demonstrated that net renal glucose output was negligible in the postabsorptive state, but it increased substantially with 4-6 wk of fasting, contributing nearly half of daily systemic glucose appearance in humans. Subsequent studies suggested that net renal glucose output during fasting reflected renal gluconeogenesis, primarily from circulating amino acids and glycerol (2, 3) . More recently, similar studies in animals have again documented the ability of the kidney to significantly increase glu-cose output in conditions of insulin deficiency (4) . Although these observations underscore the potential role of the kidney in glucose regulation in specific circumstances, they have been interpreted to indicate that the kidney is unimportant under most conditions. All in vivo studies suggesting a minimal role for the kidney in glucose metabolism in postabsorptive conditions ( 1-4) used the arteriovenous balance technique, a method which has limitations that have not been sufficiently emphasized. It is conceivable that glucose production could take place in one part of the kidney with simultaneous utilization ofglucose occurring in a separate anatomic location in the same organ. If this were the case, the two processes would tend to cancel each other out and measurement of net renal glucose balance could lead to the erroneous conclusion that the kidney is not an important site of either glucose utilization or production.
Substantial in vitro evidence indicates that the kidney is capable of both glucose production and utilization. Krebs and co-workers (5, 6) demonstrated that the biochemical machinery is in place in cells of the proximal convoluted tubule to efficiently convert 3-carbon precursors to glucose, particularly glycerol and glutamine. At the same time, cells of the distal nephron and those in the interstitial medulla are very active in glucose uptake and oxidation (7, 8) . If renal glucose production and utilization occur at significant rates and are divergently regulated, this would be ofconsiderable potential significance. The present studies were therefore undertaken to determine whether simultaneous renal glucose production and utilization occur in conscious dogs, and whether these processes are responsive to physiological hyperinsulinemia, using arteriovenous balance measurements combined with a tracer technique.
Methods
Animals and surgery. Studies were performed in 20-25-kg female mongrel dogs (n = 12). 7-10 d before the experiment a laparotomy was performed under halothane anesthesia. A silastic sampling catheter (0.040" ID and 0.085" OD) was placed midway into the left renal vein via the inferior vena cava and secured with a pursestring suture; the gonadal vein was ligated. In addition, a small (0.027" ID and 0.047" OD) nonobstructive infusion catheter was inserted into the midportion of the left renal artery and also secured with a pursestring suture. A third catheter was placed in the aorta via the left femoral artery. All catheters were filled with heparinized saline, ligated, and tunneled to a subcutaneous pocket as previously described (9 Whole body glucose rate of appearance (R,) was calculated using the steady-state formula:
where INF is the [3-3H] glucose infusion rate (dpm/min).
Left renal fractional extraction of glucose (FE.) was calculated using the following formula:
where [Glu ] = plasma glucose concentration and SA refers to tritiated glucose specific activity. The numerator in this formula represents
[3H]glucose radioactivity extracted by the kidney and the denominator represents arterial 3H glucose radioactivity.
Left renal glucose uptake was calculated using the formulae,
Since glycosuria was not present, left renal glucose utilization was assumed to be equal to glucose uptake. Left renal glucose production was calculated using the following formula: (6) The percent of systemic glucose production derived from glycerol was calculated using the following formula:
This is a standard product-precursor calculation which takes into account the fact that 2 moles ofglycerol are required to produce 1 mole of glucose. The rate ofglycerol-derived gluconeogenesis (Gly -. Glu) was calculated using the following formula: Gly -. Glu = % glucose Ra from glycerol x Glu Ra (8) The contribution of the kidney to the rate of appearance of [ "'C]-glucose derived from glycerol was obtained from the following formula:
2(14C Gly SA.) (9) The numerator in the formula represents the renal vein glucose [`C ]-glucose radioactivity in excess of that anticipated from the known arterial glucose "`C radioactivity and the fractional extraction of3H glucose (i.e., that [ '4C]glucose which has been newly generated in the kidney).
The denominator in the formula is the precursor pool (glycerol) specific activity in dpm/,gmol, again taking into account the fact that 2 moles of glycerol are required to generate 1 mole of glucose. This formula will underestimate actual renal gluconeogenesis from glycerol to the extent that the kidney metabolizes newly synthesized [ '4C]glucose.
Statistics. All values are expressed as mean±SEM. Data obtained at baseline in each group were compared to those from the study period using a paired t test; data between groups following intrarenal infusions were compared using nonpaired t test. All P values < 0.05 were considered statistically significant ( 17) .
Results
Arterial insulin levels were similar in the insulin and the saline groups, before and during the infusions, respectively (Table I) . During intrarenal infusion, renal vein insulin concentration more than doubled in the insulin group (P < 0.05), whereas there was no change in the saline group pmol/l) ( Table I) . Left renal plasma flow at baseline was 4.0±1.0 ml * kg-* minm in the insulin group and 4.9±0.6 ml -kg-* minm-I in the saline group, and remained comparable (P = NS) during the study period (4.7±0.8 and 5.5±1.4 ml -kg-I * min', in the insulin and saline groups, respectively). Fig. 1 shows plasma glucose concentration during the baseline and study periods. Arterial plasma glucose averaged 5.4±0.2 and 5.4±0.1 mmol/l in the insulin group and 5.6±0.2 and 5.5±0.2 mmol/l in the saline group during the baseline and study periods, respectively. Baseline renal vein glucose concentrations decreased from 5.3±0.2 to 4.9±0.1 mmol/l during intrarenal infusion in the insulin group (P < 0.05), but no change was observed in the saline group (5.5±0.2 vs. 5.5±0.3 mmol/l, P = NS). As a consequence, net glucose balance in the insulin group changed from + 0.10±0.04 mmol/l at baseline to + 0.51±0.04 mmol/l after intrarenal insulin infusion (P < 0.01 ), but did not change significantly after intrarenal saline infusion (+ 0.20±0.08 vs. + 0.03±0.08 mmol/l during the baseline and study periods, respectively, P = NS).
[3H ]- (Fig. 3) increased from 3.1±0.4 to 5.4±1.4 Mmol * kg-' I min-' during intrarenal infusion in the insulin group (P < 0.01), whereas no change occuffed in the saline group (2.7±0.5 vs 2.4±1.0 rmol kg' I min-', P = NS). After intrarenal infusion, left renal glucose production (Fig. 4) glycerol SA increased slightly following intrarenal insulin from an average 7.9±0.9 to 8.8±0.5 dpm/nmol (P < 0.05) but did not change following intrarenal saline infusion (6.4±0.5 vs 6.3±0.8 dpm/nmol, P = NS). Arterial glycerol concentration decreased from 92±8 to 76± 10 ,mol/L (P < 0.05) in the insulin group and did not change in the saline group (76±6 vs 81±7 ,mol/l, P = NS). Plasma FFA concentration decreased from 702±33 to 604±14 ,umol/l in the insulin group (P < 0.05), whereas there was no effect in the saline group (606±68 vs 616±65 ,umol/l, P = NS). Systemic glycerol Ra increased slightly, but not significantly, after intrarenal saline infusion but decreased (P < 0.05) following intrarenal insulin infusion (Table II) . Systemic gluconeogenesis from glycerol declined (P < 0.05) by -30% following IR insulin infusion, whereas it did not change in the saline group (P = NS). Likewise, renal gluconeogenesis from glycerol decreased (P < 0.05) by 25% after intrarenal insulin infusion, but did not change in response to intrarenal saline (P = NS).
Discussion
The present studies confirm previous studies in dogs (4) and uptake by the kidney at approximately equal rates. Our observation that the kidney accounts for -30% ( 15% in each kidney) of systemic glucose turnover strongly contrasts with the prevailing view that the liver is the only significant source of glucose production in the postabsorptive state ( 18) . Moreover, the evidence that one quarter to one third of systemic glucose disappearance occurs in the kidney demonstrates the potential impact of changes in renal glucose uptake on overall glucose homeostasis. These observations require a more complicated model of glucoregulation, taking into consideration possible different effects on the kidney and liver of the large number of hormones (19) (20) (21) and substrates (22) (23) (24) known to affect systemic glucose metabolism. The approximate equality of renal glucose production and utilization, which results in modest to negligible net glucose balance, could be interpreted to indicate that the role of these two processes in whole body glucose homeostasis during the postabsorptive period is minimal. However, the divergent effects of physiological increases in plasma insulin concentration on renal glucose production and utilization (suppression and stimulation, respectively) underscore the potential importance of changes in renal glucose metabolism on systemic glucoregulation, both in normal physiology and in disease states such as diabetes mellitus and chronic renal insufficiency.
The combination of arteriovenous balance and isotope dilution can effectively partition uptake and release in a tissue bed and has been previously applied to the study of glucose, fatty acid, and amino acid metabolism in such diverse tissues as liver (25) , kidney (26) , and extremity (27, 28) . The principle balance from zero to net uptake. The intrarenal insulin infusion rate used in these studies (0.05 mU -kg-' -min ') was selected to produce insulin levels in renal plasma in a range similar to that which occurs in the postprandial period in dogs (10) . A (30) . We have performed separate studies in which insulin was infused systemically at a rate similar to the rate of intrarenal insulin infusion used in the present study; in those experiments, a comparable degree of inhibition of adipose tissue lipolysis was observed but there was no effect on renal or systemic glucose production (unpublished observations). It is therefore unlikely that the -20% decrease in plasma FFA was responsible for the degree of inhibition of renal glucose release observed in the present studies. Additional studies will be required to assess the role of plasma FFA concentrations, which are known to influence rates of hepatic gluconeogenesis ( 31 ), on renal glucose production. The -25% decrease in systemic gluconeogenesis from glycerol is likely entirely the result of a proportional decrease in glycerol availability.
According to our findings, glycerol-derived gluconeogenesis accounts for -10% of systemic and renal glucose production, and -20% of total glycerol conversion to glucose occurs in the kidney ( -10% in each kidney). During intrarenal insulin infusion renal glucose output decreased by -75%, while renal glycerol conversion to glucose decreased only slightly, representing -25% of renal glucose output during insulin infusion. In fact, it is not at all unlikely that the decrease in renal conversion of glycerol to glucose reflects a mere reduction in glycerol availability, similar to systemic gluconeogenesis from glycerol, and that insulin has minimal or no direct effect on renal gluconeogenesis from glycerol. These findings strongly suggest that suppression ofrenal glucose production by physiological hyperinsulinemia is due primarily to an inhibitory effect on renal glycogenolysis. However, the data could also reflect inhibition by insulin of gluconeogenesis from substrates other than glycerol, such as glutamine. In either case, our results are concordant with other reports (4, 32) which indicate that insulin, similar to its effect in the liver (33) , inhibits renal glucose production. The effects of insulin in situations where concentrations of glucose and other substrates are changing, such as occurs after a mixed meal, are difficult to predict and their elucidation will require further study.
Stimulation of renal glucose uptake by insulin may reflect effects on both oxidative and non-oxidative glucose disposal, similar to its action on peripheral tissues (34) . Glucose utilization is minimal in the proximal convoluted tubule (35) , whereas active anaerobic glycolysis with lactate formation (36) and glycogen synthesis and storage (37) occur in the distal nephron. Oxidative glucose disposal is only known to occur to a significant extent in the interstitial medullary cells (38) . The insulin-mediated increase in renal glucose uptake in our study thus likely occurs in the distal nephron, and may reflect an enhancement in both glycogen synthesis and glucose oxidation. Glycogen deposition has been documented in the distal nephron in humans (39) . The fact that glycogen accumulation in the ascending limb of the loop of Henle was reported in hyperglycemic rats (40) and in poorly controlled diabetic patients (39) has been taken as evidence that glycogen synthesis and storage in the distal nephron is essentially dependent upon glucose supply (41 ) . Since the predominant effect ofinsulin in our study appears to be on distal nephron glycogenolysis, and not on proximal tubular gluconeogenesis, there should not have been a decrease in glucose supply to the distal nephron. Therefore, insulin may have stimulated glycogen synthesis and simultaneously inhibited glycogenolysis in the distal nephron. Alternatively, the insulin-mediated increase in renal glucose uptake may be due solely to increased renal medullary glucose oxidation. It is well established that insulin stimulates sodium tubular transport (42) , an effect that occurs predominantly in the diluting segment of the distal nephron (43) . Since fasting ( 1-3 ) or diabetes (4) could be the result of a marked decrease in glucose uptake, an increase in renal glucose production, or a combination of the two. Increased gluconeogenesis (46) appears to be an important mechanism by which diabetic individuals maintain higher glucose turnover rates, and is a direct consequence of impaired insulin secretion and action (47). The relative contribution of direct effects of insulin deficiency and impaired insulin action versus indirect effects of increased circulating substrates (31 ) to increased hepatic or renal gluconeogenesis in diabetes is not known. Conversely, an imbalance between renal glucose production and utilization could result in a substantial decrease in net renal glucose output which would contribute to lower plasma glucose concentrations. In fact, hypoglycemia is a frequent occurrence in hospitalized patients with chronic renal insufficiency (48) . The proportionately greater loss of renal cortex compared to medulla in chronic renal diseases (49) could create a situation in which renal glucose production is impaired while renal glucose uptake is relatively preserved.
In summary, we have demonstrated that the kidney is responsible for 30% of endogenous glucose turnover in the postabsorptive state in conscious dogs. Physiological hyperinsulinemia suppresses renal glucose production and stimulates glucose uptake. Since renal glycerol conversion to glucose was minimally affected, insulin may exert a primary inhibitory effect on renal glycogen degradation. Renal glucose utilization reflects renal glycogen synthesis and storage as well as glucose oxidation in the distal nephron.
